Low-dose aspirin is not effective as an adjunct treatment for HIV infection among people living with HIV on dolutegravir-based antiretroviral therapy: A randomised double-blind, parallel-group placebo-controlled trial

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2025-08-29
DOI
https://doi.org/10.1371/journal.pone.0331087
Primary Topic
HIV Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Low-dose aspirin is not effective as an adjunct treatment for HIV infection among people living with HIV on dolutegravir-based antiretroviral therapy: A randomised double-blind, parallel-group placebo-controlled trial

Grace Shayo, Furaha Lyamuya, Peter P. Kunambi, Godfrey Barabona et al.
PLoS ONE
HIV Research and Treatment
article

Low-dose aspirin is not effective as an adjunct treatment for HIV infection among people living with HIV on dolutegravir-based antiretroviral therapy: A randomised double-blind, parallel-group placebo-controlled trial

Grace Shayo, Furaha Lyamuya, Peter P. Kunambi, Godfrey Barabona, Philip Sasi, Tosi Mwakyandile, Takamasa Ueno, Ferdinand Mugusi
article en

Abstract

No abstract available for this paper.
PLoS ONEVol. 20(8)
Muhimbili University of Health and Allied Sciences (TZ), Kumamoto University (JP)
Styrelsen för Internationellt Utvecklingssamarbete, Japan Student Services Organization, National Institutes of Health
Openalex Percentile: Top 75%
HIV Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.